<DOC>
	<DOCNO>NCT02094950</DOCNO>
	<brief_summary>This single arm clinical trial establish feasibility conduct clinical trial acupuncture reduce dyspnea among lung cancer survivor complete chemoradiotherapy . Twelve subject dyspnea recruit clinical trial . Up 10 session acupuncture deliver course 8-10 week . The primary outcome dyspnea measure English version Cancer Dyspnea Scale completion intervention .</brief_summary>
	<brief_title>Acupuncture Feasibility Trial Dyspnea Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Dyspnea</mesh_term>
	<criteria>Diagnosis Lung Cancer ( Non small cell small cell eligible ) Completion concurrent CRT least 6 month prior randomization . Dyspnea worsen Chemoradiotherapy , lead ATS dyspnea score great equal 2 ( Walks slow people age level breathlessness stop breath walk pace level ) Ability understand write English Willingness adhere studyrelated procedure Age 18 year old ECOG Performance Status 13 Current receipt therapy treatment relate pneumonitis 3 week . Surgical resection LC ( lobectomy pneumonectomy ) Another organic cause dyspnea necessitate treatment ( eg pleural effusion appropriate thoracentesis , rapidly progressive intrathoracic recurrence , symptomatic pulmonary embolus CRT , untreated anemia hemoglobin8 g/dL ) Current bleed disorder history Life expectancy 12 week , assess primary oncologist</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>concurrent chemotherapy</keyword>
	<keyword>concurrent radiation</keyword>
</DOC>